Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Ny Eso 1 Containing Artificial Adjuvant Vector Cell Used For Treating Cancer
Abstract: The present invention addresses the problem of providing an aAVC-NY-ESO-1 cell, which stably expresses NY-ESO-1 and is clinically applicable, in order to use the aAVC-NY-ESO-1 cell to treat a patient with NY-ESO-1 expressing cancer. The present invention provides a human-derived cell including, for example, a polynucleotide encoding CD1d, and a polynucleotide encoding NY-ESO-1 which is operably linked to an inducible promoter or a fragment thereof.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
22 June 2022
Publication Number
26/2022
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
patent@depenning.com
Parent Application
Applicants
ASTELLAS PHARMA INC.
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
RIKEN
2-1, Hirosawa, Wako-shi, Saitama
3510198
Inventors
1. AKIBA Ayaka
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
2. OKUDAIRA Tatsuya
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
3. MASUHARA Yasuhide
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
4. OHSUMI Keisuke
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo
1038411
5. FUJII Shinichiro
c/o RIKEN, 2-1, Hirosawa, Wako-shi, Saitama
3510198
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202247035726-Correspondence_Form 26_19-12-2022.pdf | 2022-12-19 |
| 1 | 202247035726.pdf | 2022-06-22 |
| 2 | 202247035726-STATEMENT OF UNDERTAKING (FORM 3) [22-06-2022(online)].pdf | 2022-06-22 |
| 2 | 202247035726-FORM 3 [30-11-2022(online)].pdf | 2022-11-30 |
| 3 | 202247035726-SEQUENCE LISTING(PDF) [22-06-2022(online)].pdf | 2022-06-22 |
| 3 | 202247035726-FORM-26 [08-08-2022(online)].pdf | 2022-08-08 |
| 4 | 202247035726-SEQUENCE LISTING [22-06-2022(online)].txt | 2022-06-22 |
| 4 | 202247035726-Correspondence_Form-1 And POA_04-08-2022.pdf | 2022-08-04 |
| 5 | 202247035726-PRIORITY DOCUMENTS [22-06-2022(online)].pdf | 2022-06-22 |
| 5 | 202247035726-FORM-26 [18-07-2022(online)].pdf | 2022-07-18 |
| 6 | 202247035726-Proof of Right [18-07-2022(online)].pdf | 2022-07-18 |
| 6 | 202247035726-FORM 1 [22-06-2022(online)].pdf | 2022-06-22 |
| 7 | 202247035726-DRAWINGS [22-06-2022(online)].pdf | 2022-06-22 |
| 7 | 202247035726-COMPLETE SPECIFICATION [22-06-2022(online)].pdf | 2022-06-22 |
| 8 | 202247035726-DECLARATION OF INVENTORSHIP (FORM 5) [22-06-2022(online)].pdf | 2022-06-22 |
| 9 | 202247035726-DRAWINGS [22-06-2022(online)].pdf | 2022-06-22 |
| 9 | 202247035726-COMPLETE SPECIFICATION [22-06-2022(online)].pdf | 2022-06-22 |
| 10 | 202247035726-FORM 1 [22-06-2022(online)].pdf | 2022-06-22 |
| 10 | 202247035726-Proof of Right [18-07-2022(online)].pdf | 2022-07-18 |
| 11 | 202247035726-PRIORITY DOCUMENTS [22-06-2022(online)].pdf | 2022-06-22 |
| 11 | 202247035726-FORM-26 [18-07-2022(online)].pdf | 2022-07-18 |
| 12 | 202247035726-SEQUENCE LISTING [22-06-2022(online)].txt | 2022-06-22 |
| 12 | 202247035726-Correspondence_Form-1 And POA_04-08-2022.pdf | 2022-08-04 |
| 13 | 202247035726-SEQUENCE LISTING(PDF) [22-06-2022(online)].pdf | 2022-06-22 |
| 13 | 202247035726-FORM-26 [08-08-2022(online)].pdf | 2022-08-08 |
| 14 | 202247035726-STATEMENT OF UNDERTAKING (FORM 3) [22-06-2022(online)].pdf | 2022-06-22 |
| 14 | 202247035726-FORM 3 [30-11-2022(online)].pdf | 2022-11-30 |
| 15 | 202247035726.pdf | 2022-06-22 |
| 15 | 202247035726-Correspondence_Form 26_19-12-2022.pdf | 2022-12-19 |